Robinson Elliott sold 0 shares of Hinge Health, Inc. on Nov 4, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
Director
DIR
Filed Nov 6, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
—Shares × reported price
Shares traded
0Class A Common Stock
Price per share
Price unknownReported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
0Indirect · See footnote
Trade date
Nov 4, 2026Sell
Filed
Nov 6, 2026, 4:05 PM ET2-day reporting delay
Accession
0001193125-26-451823Code S · Transaction 394613
How reported position traded is calculated

A positive, reliable share quantity and nonnegative holdings are required.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 5, 2026Sell0——Trade 394622
2 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

HNGE price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
HNGE · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −15%1w ago −0.4%1d ago +0.9%
Returns since7d −0.3%30d90d180d1y

Footnotes in full

F1: On November 4, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 776 and 728 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $116.61. These shares were sold in multiple transactions at prices ranging from $116.02 to $116.79. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2: On November 4, 2026, BVP X and BVP X Inst sold 498 and 468 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $117.14. These shares were sold in multiple transactions at prices ranging from $117.00 to $117.50. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3: On November 4, 2026, BVP X and BVP X Inst sold 119 and 112 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $118.00. These shares were sold in multiple transactions at prices ranging from $118.00 to $118.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F4: On November 4, 2026, BVP X and BVP X Inst sold 8,210 and 7,708 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $119.61. These shares were sold in multiple transactions at prices ranging from $119.24 to $120.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F5: On November 4, 2026, BVP X and BVP X Inst sold 14,059 and 13,197 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $120.57. These shares were sold in multiple transactions at prices ranging from $120.00 to $121.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F6: On November 4, 2026, BVP X and BVP X Inst sold 18,269 and 17,150 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $121.35. These shares were sold in multiple transactions at prices ranging from $121.00 to $122.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F7: On November 4, 2026, BVP X and BVP X Inst sold 3,494 and 3,279 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $122.62. These shares were sold in multiple transactions at prices ranging from $122.09 to $122.99. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F8: On November 4, 2026, BVP X and BVP X Inst sold 4,051 and 3,802 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $123.52. These shares were sold in multiple transactions at prices ranging from $123.00 to $123.99. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F9: On November 4, 2026, BVP X and BVP X Inst sold 2,104 and 1,976 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $124.45. These shares were sold in multiple transactions at prices ranging from $124.09 to $124.90. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F10: On November 5, 2026, BVP X and BVP X Inst sold 1,825 and 1,712 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $119.77. These shares were sold in multiple transactions at prices ranging from $119.50 to $119.98. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F11: On November 5, 2026, BVP X and BVP X Inst sold 2,265 and 2,126 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $120.38. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.97. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F12: On November 5, 2026, BVP X and BVP X Inst sold 318 and 299 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $121.19. These shares were sold in multiple transactions at prices ranging from $121.00 to $121.68. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F13: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities.